Cadaveric kidney transplantation in patients with lymphocytotoxic autoantibodies.
Emonds
M P
MP
Tissue Typing Laboratory, Bloodbank Belgian Red Cross, Leuven.
Dendievel
J
J
Roels
L
L
Waer
M
M
Vanrenterghem
Y
Y
Vermylen
C
C
D000961:Antilymphocyte Serum / Q000032:analysis*; D001323:Autoantibodies / Q000032:analysis*; D001402:B-Lymphocytes / Q000276:immunology; D002102:Cadaver; D016572:Cyclosporine / Q000008:administration & dosage; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology*; D006680:HLA Antigens / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D007075:Immunoglobulin M / Q000032:analysis; D016030:Kidney Transplantation / Q000276:immunology*; D011183:Postoperative Complications / Q000276:immunology*; D012083:Renin / Q000097:blood; D013601:T-Lymphocytes / Q000276:immunology
D000961:Antilymphocyte Serum; D001323:Autoantibodies; D006680:HLA Antigens; D007075:Immunoglobulin M; D016572:Cyclosporine; D012083:Renin